Investors Research Corp Abb Vie Inc. Transaction History

Investors Research Corp

$446 Million
Q3 2024

A detailed history of Investors Research Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Investors Research Corp holds 741 shares of ABBV stock, worth $132,787. This represents 0.03% of its overall portfolio holdings.

Number of Shares

741

Previous 741 -0.0%

Holding current value

$132,787

Previous $127,000 14.96%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $197,058 - $224,529	-1,233 Reduced 62.46%	741 $134,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $2,252 - $2,803	17 Added 0.87%	1,974 $265,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $2,952 - $3,386	22 Added 1.14%	1,957 $263,000
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $39,496 - $50,213	287 Added 17.42%	1,935 $296,000
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $1.78 Million - $2.21 Million	-13,487 Reduced 89.11%	1,648 $267,000
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $6,207 - $6,915	59 Added 0.39%	15,135 $1.71 Million
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $28,132 - $30,970	-275 Reduced 1.79%	15,076 $1.63 Million
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $8,048 - $10,867	-100 Reduced 0.65%	15,351 $1.65 Million
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $25,773 - $30,249	-300 Reduced 1.9%	15,451 $1.35 Million
Q2 2020 Jul 21, 2020	BUY	$73.37 - $98.18 $7,190 - $9,621	98 Added 0.63%	15,751 $1.55 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $3,225 - $4,889	-50 Reduced 0.32%	15,653 $1.19 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $1,803 - $2,256	-25 Reduced 0.16%	15,703 $1.39 Million
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $9,447 - $11,358	-150 Reduced 0.94%	15,728 $1.19 Million
Q2 2019 Jul 08, 2019	BUY	$65.7 - $83.98 $908,302 - $1.16 Million	13,825 Added 673.4%	15,878 $1.16 Million
Q1 2019 Apr 23, 2019	BUY	$77.14 - $90.79 $158,368 - $186,391	2,053 New	2,053 $165,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.

Account

Investors Research Corp Abb Vie Inc. Transaction History